• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15RWC W/ 3L RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX15RWC W/ 3L RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX15RW30C
Device Problem Decrease in Pressure (1490)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/27/2018
Event Type  malfunction  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during prime, the occlusion pressure would precipitously fall below 300 mmhg.The pump was checked by other perfusionists, no shunts were open.First, the pressure transducer was replaced, same problem occurred.Then, the raceway tubing was replaced, same problem occurred.Next, a flow probe was put distally from the oxygenator and the flow was accurate.Finally, the venous line was disconnected and the gravity method was used until satisfaction.*no known impact or consequences to the patient, *product was not changed out, *unknown if the procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 14, 2018.(b)(4).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.(b)(4).The returned sample was visually inspected.No obvious anomaly such as break in the appearance was found.The blood phase of the actual sample was filled with colored saline solution while the blood outlet port side was clamped and air sent into the blood phase from the blood inlet port to observe for any leak in which none was observed.The circuit was then primed and filled with saline solution.The strength of occlusion of the roller pump was adjusted to be optimal and the blood outlet port of the actual sample was clamped with forceps.The flow rate of the roller pump was gradually increased while the pressure against the tubes was determined.During this test, the pressure against the tubes never dropped.During the investigation, the actual sample did not present any inherent anomalies, including a leak, which could have led to this complaint.It is difficult to determine the cause of this complaint from the available information.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX15RWC W/ 3L RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key7876507
MDR Text Key120263633
Report Number1124841-2018-00226
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450783
UDI-Public(01)00699753450783
Combination Product (y/n)N
PMA/PMN Number
K151389
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 10/29/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2020
Device Model Number3CX*FX15RW30C
Device Catalogue NumberN/A
Device Lot NumberWA08
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/20/2018
Was the Report Sent to FDA? No
Date Manufacturer Received10/25/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-